170 related articles for article (PubMed ID: 37796506)
1. Epigenetic Profiles of Triple-Negative Breast Cancers of African American and White Females.
Ensenyat-Mendez M; Solivellas-Pieras M; Llinàs-Arias P; Íñiguez-Muñoz S; Baker JL; Marzese DM; DiNome ML
JAMA Netw Open; 2023 Oct; 6(10):e2335821. PubMed ID: 37796506
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas.
Huo D; Hu H; Rhie SK; Gamazon ER; Cherniack AD; Liu J; Yoshimatsu TF; Pitt JJ; Hoadley KA; Troester M; Ru Y; Lichtenberg T; Sturtz LA; Shelley CS; Benz CC; Mills GB; Laird PW; Shriver CD; Perou CM; Olopade OI
JAMA Oncol; 2017 Dec; 3(12):1654-1662. PubMed ID: 28472234
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Racial/Ethnic Differences in Treatment and Mortality Among Women With Triple-Negative Breast Cancer.
Cho B; Han Y; Lian M; Colditz GA; Weber JD; Ma C; Liu Y
JAMA Oncol; 2021 Jul; 7(7):1016-1023. PubMed ID: 33983438
[TBL] [Abstract][Full Text] [Related]
4. Metabolic profile of triple-negative breast cancer in African-American women reveals potential biomarkers of aggressive disease.
Kanaan YM; Sampey BP; Beyene D; Esnakula AK; Naab TJ; Ricks-Santi LJ; Dasi S; Day A; Blackman KW; Frederick W; Copeland RL; Gabrielson E; Dewitty RL
Cancer Genomics Proteomics; 2014; 11(6):279-94. PubMed ID: 25422359
[TBL] [Abstract][Full Text] [Related]
5. Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians.
Ademuyiwa FO; Tao Y; Luo J; Weilbaecher K; Ma CX
Breast Cancer Res Treat; 2017 Feb; 161(3):491-499. PubMed ID: 27915434
[TBL] [Abstract][Full Text] [Related]
6. Reproductive factors and the risk of triple-negative breast cancer in white women and African-American women: a pooled analysis.
Ma H; Ursin G; Xu X; Lee E; Togawa K; Duan L; Lu Y; Malone KE; Marchbanks PA; McDonald JA; Simon MS; Folger SG; Sullivan-Halley J; Deapen DM; Press MF; Bernstein L
Breast Cancer Res; 2017 Jan; 19(1):6. PubMed ID: 28086982
[TBL] [Abstract][Full Text] [Related]
7. Genetic Ancestry using Mitochondrial DNA in patients with Triple-negative breast cancer (GAMiT study).
Rao R; Rivers A; Rahimi A; Wooldridge R; Rao M; Leitch M; Euhus D; Haley BB
Cancer; 2017 Jan; 123(1):107-113. PubMed ID: 27584945
[TBL] [Abstract][Full Text] [Related]
8. Constitutional BRCA1 Methylation and Risk of Incident Triple-Negative Breast Cancer and High-grade Serous Ovarian Cancer.
Lønning PE; Nikolaienko O; Pan K; Kurian AW; Eikesdal HP; Pettinger M; Anderson GL; Prentice RL; Chlebowski RT; Knappskog S
JAMA Oncol; 2022 Nov; 8(11):1579-1587. PubMed ID: 36074460
[TBL] [Abstract][Full Text] [Related]
9. Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer.
Sturtz LA; Melley J; Mamula K; Shriver CD; Ellsworth RE
BMC Cancer; 2014 Feb; 14():62. PubMed ID: 24495414
[TBL] [Abstract][Full Text] [Related]
10. Racial differences in RAD51 expression are regulated by miRNA-214-5P and its inhibition synergizes with olaparib in triple-negative breast cancer.
Mani C; Acharya G; Saamarthy K; Ochola D; Mereddy S; Pruitt K; Manne U; Palle K
Breast Cancer Res; 2023 Apr; 25(1):44. PubMed ID: 37081516
[TBL] [Abstract][Full Text] [Related]
11. High expression of MKK3 is associated with worse clinical outcomes in African American breast cancer patients.
Yang X; Amgad M; Cooper LAD; Du Y; Fu H; Ivanov AA
J Transl Med; 2020 Sep; 18(1):334. PubMed ID: 32873298
[TBL] [Abstract][Full Text] [Related]
12. Differentially expressed miRNAs in triple negative breast cancer between African-American and non-Hispanic white women.
Sugita B; Gill M; Mahajan A; Duttargi A; Kirolikar S; Almeida R; Regis K; Oluwasanmi OL; Marchi F; Marian C; Makambi K; Kallakury B; Sheahan L; Cavalli IJ; Ribeiro EM; Madhavan S; Boca S; Gusev Y; Cavalli LR
Oncotarget; 2016 Nov; 7(48):79274-79291. PubMed ID: 27813494
[TBL] [Abstract][Full Text] [Related]
13. Association Between Benign Breast Disease in African American and White American Women and Subsequent Triple-Negative Breast Cancer.
Newman LA; Stark A; Chitale D; Pepe M; Longton G; Worsham MJ; Nathanson SD; Miller P; Bensenhaver JM; Proctor E; Swain M; Patriotis C; Engstrom PF
JAMA Oncol; 2017 Aug; 3(8):1102-1106. PubMed ID: 28006062
[TBL] [Abstract][Full Text] [Related]
14. Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women.
O'Meara T; Safonov A; Casadevall D; Qing T; Silber A; Killelea B; Hatzis C; Pusztai L
Breast Cancer Res Treat; 2019 May; 175(1):247-259. PubMed ID: 30725384
[TBL] [Abstract][Full Text] [Related]
15. Comparative Analysis of Breast Cancer Phenotypes in African American, White American, and West Versus East African patients: Correlation Between African Ancestry and Triple-Negative Breast Cancer.
Jiagge E; Jibril AS; Chitale D; Bensenhaver JM; Awuah B; Hoenerhoff M; Adjei E; Bekele M; Abebe E; Nathanson SD; Gyan K; Salem B; Oppong J; Aitpillah F; Kyei I; Bonsu EO; Proctor E; Merajver SD; Wicha M; Stark A; Newman LA
Ann Surg Oncol; 2016 Nov; 23(12):3843-3849. PubMed ID: 27469125
[TBL] [Abstract][Full Text] [Related]
16. Hereditary Susceptibility for Triple Negative Breast Cancer Associated With Western Sub-Saharan African Ancestry: Results From an International Surgical Breast Cancer Collaborative.
Newman LA; Jenkins B; Chen Y; Oppong JK; Adjei E; Jibril AS; Hoda S; Cheng E; Chitale D; Bensenhaver JM; Awuah B; Bekele M; Abebe E; Kyei I; Aitpillah F; Adinku M; Nathanson SD; Jackson L; Jiagge E; Merajver S; Petersen LF; Proctor E; Gyan KK; Martini R; Kittles R; Davis MB
Ann Surg; 2019 Sep; 270(3):484-492. PubMed ID: 31356281
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the genomic landscapes of Barbadian and Nigerian women with triple negative breast cancer.
Hercules SM; Liu X; Bassey-Archibong BBI; Skeete DHA; Smith Connell S; Daramola A; Banjo AA; Ebughe G; Agan T; Ekanem IO; Udosen J; Obiorah C; Ojule AC; Misauno MA; Dauda AM; Egbujo EC; Hercules JC; Ansari A; Brain I; MacColl C; Xu Y; Jin Y; Chang S; Carpten JD; Bédard A; Pond GR; Blenman KRM; Manojlovic Z; Daniel JM
Cancer Causes Control; 2022 Jun; 33(6):831-841. PubMed ID: 35384527
[TBL] [Abstract][Full Text] [Related]
18. Immune Responses and Risk of Triple-negative Breast Cancer: Implications for Higher Rates among African American Women.
Ogony JW; Radisky DC; Ruddy KJ; Goodison S; Wickland DP; Egan KM; Knutson KL; Asmann YW; Sherman ME
Cancer Prev Res (Phila); 2020 Nov; 13(11):901-910. PubMed ID: 32753376
[TBL] [Abstract][Full Text] [Related]
19. Multiethnic PDX models predict a possible immune signature associated with TNBC of African ancestry.
Jiagge EM; Ulintz PJ; Wong S; McDermott SP; Fossi SI; Suhan TK; Hoenerhoff MJ; Bensenhaver JM; Salem B; Dziubinski M; Oppong JK; Aitpillah F; Ishmael K; Osei-Bonsu E; Adjei E; Baffour A; Aldrich J; Kurdoglu A; Fernando K; Craig DW; Trent JM; Li J; Chitale D; Newman LA; Carpten JD; Wicha MS; Merajver SD
Breast Cancer Res Treat; 2021 Apr; 186(2):391-401. PubMed ID: 33576900
[TBL] [Abstract][Full Text] [Related]
20. Update on triple-negative breast cancer disparities for the United States: A population-based study from the United States Cancer Statistics database, 2010 through 2014.
Scott LC; Mobley LR; Kuo TM; Il'yasova D
Cancer; 2019 Oct; 125(19):3412-3417. PubMed ID: 31282032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
